A PHASE-I STUDY OF THE CONCURRENT ADMINISTRATION OF ALPHA-2-INTERFERON AND DOXORUBICIN

被引：0
|
作者：
GREEN, MD [1 ]
SPEYER, JL [1 ]
WERNZ, JC [1 ]
BLUM, RH [1 ]
DUNLEAVY, S [1 ]
WIDMAN, T [1 ]
MUGGIA, FM [1 ]
机构：
[1] NYU MED CTR,NEW YORK,NY 10016
来源：
CLINICAL RESEARCH | 1985年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A767 / A767
页数：1
相关论文
共 50 条
  • [31] A PHASE-I TRIAL OF RECOMBINANT LEUKOCYTE ALPHA-2 INTERFERON IN PATIENTS WITH ADVANCED MALIGNANCY
    MUSS, HB
    HOMESLEY, HD
    RUDNICK, SA
    PLUNKETT, S
    CAPONERA, M
    COOPER, MR
    JACKSON, DV
    JOBSON, VN
    RICHARDS, F
    SPURR, CL
    STUART, JJ
    WELANDER, C
    WHITE, DR
    FERRARESI, RL
    NORRED, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (02): : 97 - 107
  • [32] PHASE-I COMBINED MODALITY CLINICAL-TRIAL OF INTERFERON-ALPHA-2 AND RADIOTHERAPY
    TORRISI, J
    BERG, C
    HARTER, K
    LVOVSKY, E
    YEUNG, K
    WOOLLEY, P
    BONNEM, E
    DRITSCHILO, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08): : 1453 - 1456
  • [33] IMMUNOMODULATION BY RECOMBINANT INTERFERON-ALPHA-2 IN A PHASE-I TRIAL IN PATIENTS WITH LYMPHOPROLIFERATIVE MALIGNANCIES
    OZER, H
    GAVIGAN, M
    OMALLEY, J
    THOMPSON, D
    DADEY, B
    NUSSBAUMBLUMENSON, A
    SNIDER, C
    RUDNICK, S
    FERRARESI, R
    NORRED, S
    HAN, T
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1983, 2 (06): : 499 - 515
  • [34] AN OUTPATIENT PHASE-I STUDY OF A SUBCUTANEOUS INTERLEUKIN-2 AND INTRAMUSCULAR INTERFERON-ALPHA-2A COMBINATION IN ADVANCED MALIGNANCIES
    ROSSO, R
    SERTOLI, MR
    QUEIROLO, P
    SANGUINETI, O
    BARZACCHI, MC
    MARIANI, GL
    MIGLIO, L
    VENTURINI, M
    TOMA, S
    ANNALS OF ONCOLOGY, 1992, 3 (07) : 559 - 563
  • [35] FREQUENT ADMINISTRATION OF DABIS MALEATE, A PHASE-I STUDY
    VERWEIJ, J
    PLANTING, AST
    DEBOER, M
    VANDERBURG, MEL
    STOTER, G
    ANNALS OF ONCOLOGY, 1992, 3 (03) : 241 - 242
  • [36] PHASE-I STUDY OF ESCALATING DOSE MITOXANTRONE IN COMBINATION WITH INTERFERON-ALPHA-2 IN PATIENTS WITH ADVANCED SOLID TUMORS
    GASPARINI, G
    DALFIOR, S
    POZZA, F
    PANIZZONI, GA
    FAVRETTO, S
    VONHOFF, DD
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (03) : 245 - 252
  • [37] RATIONALE FOR AND CONDUCT OF A PHASE-I CLINICAL-TRIAL WITH INTERFERON ALFA-2B PLUS DOXORUBICIN
    VONHOFF, DD
    SAROSY, G
    BROWN, TD
    KUHN, JG
    KISNER, DL
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 72 - 77
  • [38] CONCOMITANT CISPLATIN AND RECOMBINANT INTERFERON ALPHA-2B IN HEAD AND NECK-CANCER - A PHASE-I STUDY
    TOMA, S
    BENASSO, M
    MERLANO, M
    ALBANESE, E
    MUTTINI, MP
    ROSSO, R
    DRUG INVESTIGATION, 1991, 3 (05): : 341 - 343
  • [39] PHASE-I STUDY OF A COMBINATION OF RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    KURZROCK, R
    ROSENBLUM, MG
    QUESADA, JR
    SHERWIN, SA
    ITRI, LM
    GUTTERMAN, JU
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1677 - 1683
  • [40] PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER
    SPARANO, JA
    WADLER, S
    LIEBES, L
    ROBERT, NJ
    SCHWARTZ, EL
    DUTCHER, JP
    CANCER RESEARCH, 1993, 53 (15) : 3509 - 3512
12345